These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6671841)

  • 1. Abuse of pentazocine combined with tripelennamine: an interaction of pharmacological and demographic characteristics.
    True WR; Pevnick JS
    Int J Addict; 1983 Dec; 18(8):1063-71. PubMed ID: 6671841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical pharmacology of pentazocine and tripelennamine (T's and Blues).
    Lange WR; Jasinski DR
    Adv Alcohol Subst Abuse; 1986; 5(4):71-83. PubMed ID: 3751735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in abuse of pentazocine/tripelennamine (T's and Blues) associated with the addition of naloxone to pentazocine tablets.
    Poklis A
    Drug Alcohol Depend; 1984 Oct; 14(2):135-40. PubMed ID: 6510217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the interaction of pentazocine and tripelennamine: drug discrimination and mu-receptor binding assay.
    Shook JE; Kallman MJ; Martin BR; Dewey WL
    Pharmacol Biochem Behav; 1984 Dec; 21(6):877-81. PubMed ID: 6097919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate dependence alters central reward of nalbuphine or pentazocine plus tripelennamine.
    Huston-Lyons D; Bain GT; Kornetsky C
    Eur J Pharmacol; 1989 Oct; 169(1):153-7. PubMed ID: 2599009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentazocine (Talwin) and tripelennamine (Pyribenzamine): a new drug abuse combination or just a revival?
    Wadley C; Stillie GD
    Int J Addict; 1980 Nov; 15(8):1285-90. PubMed ID: 7216568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective survival in pentazocine and tripelennamine of Pseudomonas aeruginosa serotype O11 from drug addicts.
    Botsford KB; Weinstein RA; Nathan CR; Kabins SA
    J Infect Dis; 1985 Feb; 151(2):209-16. PubMed ID: 3918122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abuse of pentazocine-naloxone combination.
    Reed DA; Schnoll SH
    JAMA; 1986 Nov; 256(18):2562-4. PubMed ID: 3773159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated development of pulmonary complications due to illicit intravenous use of pentazocine and tripelennamine.
    Itkonen J; Schnoll S; Daghestani A; Glassroth J
    Am J Med; 1984 Apr; 76(4):617-22. PubMed ID: 6711575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentazocine--naloxone: another "addiction-proof" drug of abuse.
    Lahmeyer HW; Craig RJ
    Int J Addict; 1987 Nov; 22(11):1163-6. PubMed ID: 3429075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between H1-antagonists and opioids: a drug discrimination study.
    Suzuki T; Mori T; Tsuji M; Misawa M; Onodera K
    Psychopharmacology (Berl); 1997 Jun; 131(4):346-53. PubMed ID: 9226736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T's and blues. Abuse of pentazocine and tripelennamine.
    Showalter CV
    JAMA; 1980 Sep; 244(11):1224-5. PubMed ID: 7411785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentazocine and tripelennamine: a drug abuse epidemic?
    Lahmeyer HW; Steingold RG
    Int J Addict; 1980 Nov; 15(8):1219-32. PubMed ID: 7216562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IV pentazocine/methylphenidate abuse--the clinical toxicity of another Ts and blues combination.
    Carter HS; Watson WA
    J Toxicol Clin Toxicol; 1994; 32(5):541-7. PubMed ID: 7932913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of concomitant pentazocine and tripelennamine on brain-stimulation reward.
    Unterwald EM; Kornetsky C
    Pharmacol Biochem Behav; 1984 Dec; 21(6):961-4. PubMed ID: 6335254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of dopamine in the effects of pentazocine and tripelennamine.
    Hudzik TJ; Slifer BL
    Pharmacol Biochem Behav; 1990 Jul; 36(3):547-54. PubMed ID: 1974066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between pentazocine and tripelennamine on autonomic and nociceptive measures in the dog.
    Vaupel DB
    Pharmacol Biochem Behav; 1989 May; 33(1):245-51. PubMed ID: 2780781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical and psychiatric complications of pentazocine and tripelennamine abuse.
    Lahmeyer HW; Steingold RG
    J Clin Psychiatry; 1980 Aug; 41(8):275-8. PubMed ID: 7400105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic sclerosing glomerulopathy (heroin-associated nephropathy) in intravenous T's and Blues abusers.
    May DC; Helderman JH; Eigenbrodt EH; Silva FG
    Am J Kidney Dis; 1986 Dec; 8(6):404-9. PubMed ID: 3812469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nonimpact of opiate research on opiate abuse.
    Brust JC
    Neurology; 1983 Oct; 33(10):1327-31. PubMed ID: 6684228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.